We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Asks Congress For $22 Million In User Fees for Reinspections
FDA Asks Congress For $22 Million In User Fees for Reinspections
March 2, 2006
Device and drug manufacturers may find themselves digging deeper into their pockets to pay proposed FDA user fees to fund the agency’s reinspections of manufacturing plants that fail initial review.